Bisphosphonates  	Bisphosphonates  	 NNP	B-NP
and  	and  	 CC	O
atherosclerosis  	atherosclerosis  	 VBG	O
The  	The  	 DT	O
relevance  	relevance  	 NN	O
of  	of  	 IN	O
association  	association  	 NN	O
between  	between  	 IN	O
osteoporosis  	osteoporosis  	 NN	B-NP
and  	and  	 CC	O
cardiovascular  	cardiovascular  	 JJ	B-NP
disease  	disease  	 NN	I-NP
in  	in  	 IN	O
clinical  	clinical  	 JJ	B-NP
settings 	settings 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
evidence  	evidence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
biological  	biological  	 JJ	B-NP
linkage  	linkage  	 NN	I-NP
between  	between  	 IN	O
bone  	bone  	 NN	O
and  	and  	 CC	O
vascular  	vascular  	 JJ	B-NP
calcification 	calcification 	 NN	I-NP
,  	,  	 ,	O
encourage  	encourage  	 VB	O
the  	the  	 DT	O
search  	search  	 NN	O
of  	of  	 IN	O
drugs  	drugs  	 NNS	O
that  	that  	 WDT	O
may  	may  	 MD	O
act  	act  	 VB	O
as  	as  	 IN	O
dual-purpose  	dual-purpose  	 JJ	B-NP
therapies 	therapies 	 NNS	I-NP
,  	,  	 ,	O
concordantly  	concordantly  	 FW	O
enhancing  	enhancing  	 FW	B-NP
bone  	bone  	 FW	I-NP
density  	density  	 FW	I-NP
and  	and  	 CC	O
reducing  	reducing  	 VBG	B-NP
atherosclerosis 	atherosclerosis 	 NNS	I-NP
.  	.  	 .	O
Bisphosphonates  	Bisphosphonates  	 NNP	B-NP
( 	( 	 -LRB-	O
BP 	BP 	 NNP	B-NP
)  	)  	 -RRB-	O
reduce  	reduce  	 VB	O
bone  	bone  	 JJ	B-NP
resorption  	resorption  	 NN	I-NP
and  	and  	 CC	O
fracture  	fracture  	 JJ	B-NP
risk 	risk 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
also  	also  	 RB	O
seem  	seem  	 VB	O
to  	to  	 TO	O
have  	have  	 VB	O
the  	the  	 DT	O
potential  	potential  	 JJ	O
to  	to  	 TO	O
reduce  	reduce  	 VB	O
atherosclerotic  	atherosclerotic  	 JJ	B-NP
process 	process 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
unexpected  	unexpected  	 JJ	O
activity  	activity  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
their  	their  	 PRP$	O
interference  	interference  	 NN	B-NP
with  	with  	 IN	O
cholesterol  	cholesterol  	 NN	B-NP
synthesis 	synthesis 	 NN	I-NP
,  	,  	 ,	O
inflammatory  	inflammatory  	 JJ	B-NP
progression 	progression 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
oxidative  	oxidative  	 JJ	B-NP
stress 	stress 	 NN	I-NP
.  	.  	 .	O
Although  	Although  	 IN	O
most  	most  	 JJS	O
animal  	animal  	 NN	O
studies  	studies  	 NNS	O
show  	show  	 VBP	O
a  	a  	 DT	O
clear  	clear  	 JJ	O
anti-atherogenic  	anti-atherogenic  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
BP 	BP 	 NNP	I-NP
,  	,  	 ,	O
data  	data  	 NNS	O
in  	in  	 IN	O
humans  	humans  	 NNS	O
are  	are  	 VBP	O
not  	not  	 RB	O
consistent  	consistent  	 JJ	O
or  	or  	 CC	O
conclusive 	conclusive 	 NN	O
,  	,  	 ,	O
given  	given  	 VBN	O
the  	the  	 DT	O
high  	high  	 JJ	O
affinity  	affinity  	 NN	B-NP
of  	of  	 IN	I-NP
BP  	BP  	 NNP	I-NP
for  	for  	 IN	O
bone 	bone 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
prevents  	prevents  	 VBZ	O
them  	them  	 PRP	O
from  	from  	 IN	O
accumulating  	accumulating  	 VBG	O
in  	in  	 IN	O
other  	other  	 JJ	O
tissues  	tissues  	 NNS	O
at  	at  	 IN	O
the  	the  	 DT	O
concentration  	concentration  	 NN	B-NP
required  	required  	 VBN	O
to  	to  	 TO	O
exert  	exert  	 VB	O
a  	a  	 DT	O
clear  	clear  	 JJ	O
pharmacological  	pharmacological  	 JJ	B-NP
effect 	effect 	 NN	I-NP
.  	.  	 .	O
